PDF herunterladen
Thromb Haemost 2014; 112(04): 841
DOI: 10.1160/TH14-04-0325
Author Correspondence
Schattauer GmbH

Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”

Authors

  • Jack Ansell

    1   Hofstra North Shore/LIJ School of Medicine, Hempstead, New York, USA

  • Mark Crowther

    2   St. Joseph’s Healthcare, Hamilton, Ontario, Canada
    3   McMaster University , Hamilton, Ontario, Canada

  • Allison Burnett

    4   University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA
    5   University of New Mexico Hospital, Albuquerque, New Mexico, USA

  • David Garcia

    6   University of Washington Medical Center, Seattle, Washington, USA

  • Scott Kaatz

    7   Michigan State University – College of Human Medicine, Grand Rapids, Michigan, USA

  • Renato D. Lopes

    8   Duke University School of Medicine, Durham, North Carolina, USA

  • Edith Nutescu

    9   University of Illinois Hospital and Health Sciences System, University of Illinois at Chicago; Chicago, Illinois, USA

  • Lynn Oertel

    10   Massachusetts General Hospital, Boston, Massachusetts, USA

  • Terri Schnurr

    2   St. Joseph’s Healthcare, Hamilton, Ontario, Canada

  • Michael Streiff

    11   Johns Hopkins Medical Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA

  • Diane Wirth

    12   Grady Memorial, Delaware, Ohio, USA

  • Daniel Witt

    13   University of Utah College of Pharmacy, Salt Lake City, Utah, USA

  • Ann Wittkowsky

    14   UW Medicine Department of Pharmacy, University of Washington, Seattle, Washington, USA
    • for the Anticoagulation Forum
Weitere Informationen

Publikationsverlauf

Received: 13. April 2014

Accepted after major revision: 07. Mai 2014

Publikationsdatum:
04. Dezember 2017 (online)

   Lizenzen und Reprints
Preview

(Thromb Haemost 2014; 111: 781–782)